Recession, Reform Efforts Put Pressure On MedTech Venture Funding Model
This article was originally published in The Gray Sheet
Executive Summary
The recession, impending health care reform and the changing regulatory and reimbursement environment are putting pressure on the traditional medtech venture capital funding model, according to a 1report from consulting firm Ernst & Young
You may also be interested in...
VCs Warn New Device Tax Could Reduce Investments
Venture capitalists see the new medical device industry tax under health care reform as adding to mounting pressures on smaller start-ups that could lead to smaller VC investments
VCs Warn New Device Tax Could Reduce Investments
Venture capitalists see the new medical device industry tax under health care reform as adding to mounting pressures on smaller start-ups that could lead to smaller VC investments
VCs Warn New Device Tax Could Reduce Investments
Beyond the 2.3% device excise tax rate set to begin in 2013 under the recently enacted health care reform bill, VC's are concerned with potential changes in the regulatory and reimbursement environment as FDA considers revamping its 510(k) program and reliance increases on comparative effectiveness assessments.